Crosstalk between Immune Cells and Adipocytes Requires Both Paracrine Factors and Cell Contact to Modify Cytokine Secretion

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Nitta, Carolina Franco ^a   Orlando, Robert A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CONTACT; CELL LEVEL; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOCOMPETENT CELL; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PARACRINE SIGNALING; SIGNAL TRANSDUCTION; SPLEEN CELL;

ADIPOCYTES; ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; CHEMOKINE CCL2; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NIH 3T3 CELLS; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886936447     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077306     Document Type: Article

References (67)

1. Garrow JS (1988) Obesity and related diseases. London: Churchill Livingstone.
2. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
3. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
4. Duffaut C, Galitzky J, Lafontan M, Bouloumie A, (2009) Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 384: 482-485.
5. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, et al. (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15: 930-939.
6. McDonnell ME, Ganley-Leal LM, Mehta A, Bigornia SJ, Mott M, et al. (2012) B lymphocytes in human subcutaneous adipose crown-like structures. Obesity (Silver Spring) 20: 1372-1378.
7. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, et al. (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15: 914-920.
8. Winer S, Chan Y, Paltser G, Truong D, Tsui H, et al. (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15: 921-929.
9. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, et al. (2011) B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 17: 610-617.
10. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, et al. (2007) T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115: 1029-1038.
11. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46: 2347-2355.
12. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, et al. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56: 901-911.
13. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW 2nd, DeFuria J, et al. (2007) Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56: 2910-2918.
14. Ye J, Gao Z, Yin J, He Q, (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293: E1118-1128.
15. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-919; quiz 920.
16. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, et al. (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281: 26602-26614.
17. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494-1505.
18. Wellen KE, Hotamisligil GS, (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785-1788.
19. Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G, (2012) The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol 22: 557-566.
20. Bays H, Mandarino L, DeFronzo RA, (2004) Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89: 463-478.
21. Ford ES, Giles WH, Dietz WH, (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287: 356-359.
22. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438.
23. Jensen MD, (2006) Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 14Suppl 1: 20S-24S.
24. Permana PA, Menge C, Reaven PD, (2006) Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 341: 507-514.
25. Permana PA, Zhang W, Wabitsch M, Fischer-Posovszky P, Duckworth WC, et al. (2009) Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages. Am J Physiol Endocrinol Metab 296: E1076-1084.
26. Suganami T, Nishida J, Ogawa Y, (2005) A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25: 2062-2068.
27. Gonzales AM, Orlando RA, (2008) Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond) 5: 17.
28. Samuvel DJ, Sundararaj KP, Li Y, Lopes-Virella MF, Huang Y, (2010) Adipocyte-mononuclear cell interaction, Toll-like receptor 4 activation, and high glucose synergistically up-regulate osteopontin expression via an interleukin 6-mediated mechanism. J Biol Chem 285: 3916-3927.
29. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M, (2003) Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 300: 674-678.
30. Xie L, Ortega MT, Mora S, Chapes SK, (2010) Interactive changes between macrophages and adipocytes. Clin Vaccine Immunol 17: 651-659.
31. Bruun JM, Lihn AS, Pedersen SB, Richelsen B, (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90: 2282-2289.
32. Christiansen T, Richelsen B, Bruun JM, (2005) Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 29: 146-150.
33. Ruan H, Zarnowski MJ, Cushman SW, Lodish HF, (2003) Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem 278: 47585-47593.
34. Avitsur R, Stark JL, Dhabhar FS, Sheridan JF, (2002) Social stress alters splenocyte phenotype and function. J Neuroimmunol 132: 66-71.
35. Sun S, Ji Y, Kersten S, Qi L, (2012) Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr 32: 261-286.
36. Kruisbeek AM (2001) Isolation of mouse mononuclear cells. Curr Protoc Immunol Chapter 3: Unit 3 1.
37. Livak K (1997) ABI Prism 7700 Sequence Detection System. User Bulletin 2. In: Biosystems PA, Foster City, CA.
38. Fain JN, Bahouth SW, Madan AK, (2004) TNFalpha release by the nonfat cells of human adipose tissue. Int J Obes Relat Metab Disord 28: 616-622.
39. Fain JN, (2010) Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010: 513948.
40. Hotamisligil GS, Shargill NS, Spiegelman BM, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
41. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM, (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415.
42. Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, et al. (2003) Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 88: 1055-1058.
43. Juge-Aubry CE, Somm E, Pernin A, Alizadeh N, Giusti V, et al. (2005) Adipose tissue is a regulated source of interleukin-10. Cytokine 29: 270-274.
44. Gotoh K, Inoue M, Masaki T, Chiba S, Shimasaki T, et al. (2012) A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver. Diabetes 61: 1994-2003.
45. Liu ZG, (2005) Molecular mechanism of TNF signaling and beyond. Cell Res 15: 24-27.
46. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, et al. (1997) Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272: 21096-21103.
47. Takeda K, Akira S, (2004) TLR signaling pathways. Semin Immunol 16: 3-9.
48. Ross R, (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
49. Guilherme A, Virbasius JV, Puri V, Czech MP, (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
50. Ji Y, Sun S, Xu A, Bhargava P, Yang L, et al. (2012) Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem 287: 13561-13571.
51. Wu L, Parekh VV, Gabriel CL, Bracy DP, Marks-Shulman PA, et al. (2012) Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc Natl Acad Sci U S A 109: E1143-1152.
52. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, et al. (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325: 612-616.
53. Yamashita A, Soga Y, Iwamoto Y, Yoshizawa S, Iwata H, et al. (2007) Macrophage-adipocyte interaction: marked interleukin-6 production by lipopolysaccharide. Obesity (Silver Spring) 15: 2549-2552.
54. De Taeye BM, Novitskaya T, McGuinness OP, Gleaves L, Medda M, et al. (2007) Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab 293: E713-725.
55. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM, (1994) Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 91: 4854-4858.
56. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS, (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610-614.
57. Abderrahim-Ferkoune A, Bezy O, Chiellini C, Maffei M, Grimaldi P, et al. (2003) Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. J Lipid Res 44: 994-1000.
58. Alberti L, Gilardini L, Zulian A, Micheletto G, Peri G, et al. (2009) Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Atherosclerosis 202: 455-460.
59. Rajala MW, Scherer PE, (2003) Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144: 3765-3773.
60. Idriss HT, Naismith JH, (2000) TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 50: 184-195.
61. Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T, (2010) Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49: 1215-1228.
62. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, et al. (1990) A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63: 251-258.
63. Alexopoulou L, Pasparakis M, Kollias G, (1997) A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol 27: 2588-2592.
64. Georgopoulos S, Plows D, Kollias G, (1996) Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 46: 86-97.
65. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, et al. (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27: 84-91.
66. Lappas M, Yee K, Permezel M, Rice GE, (2005) Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology 146: 1491-1497.
67. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF, (2002) Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 51: 1319-1336.